710
Participants
Start Date
October 31, 2002
Primary Completion Date
February 29, 2016
Study Completion Date
February 29, 2016
Atazanavir
Tablets, Oral, 400 mg, once daily, indefinitely
Atazanavir/Ritonavir
Tablets, Oral, 300/100 mg, once daily, indefinitely
Tenofovir/Emtricitabine
Tablets, Oral, 300/200 mg, once daily, indefinitely
Lopinavir/ritonavir
Tablets, Oral, 400/100 mg, twice daily, indefinitely
Local Institution, Lima
Local Institution, Barranco
Local Institution, Lima
Local Institution, Lima
Local Institution, Taipei
Local Institution, Taipei
Local Institution, Kaohsiung City
Local Institution, Budapest
Local Institution, Buenos Aires
Local Institution, Buenos Aires
Local Institution, Buenos Aires
Local Institution, Meadowdale
Local Institution, Buenos Aires
Local Institution, San José
Local Institution, Rosario
Local Institution, Johannesburg
Local Institution, Westdene
Local Institution, Panama City
Local Institution, Port Elizabeth
Local Institution, Rugby
Local Institution, Observatory
Local Institution, Bloemfontein
Local Institution, Torino
Local Institution, Bangkok
Local Institution, Bangkok
Local Institution, Jakarta
Local Institution, Bangkok
Local Institution, Campinas
Local Institution, Córdoba
Local Institution, Mexico City
Local Institution, Milan
Local Institution, Milan
Local Institution, Rio de Janeiro - Rj
Local Institution, Madrid
Local Institution, Madrid
Local Institution, Madrid
Local Institution, Madrid
Jemsek Clinic, Huntersville
Sbma Research, Llc, Miami Beach
St Josephs Cmprhnsv Rsch Inst, Tampa
Local Institution, Seville
Local Institution, Modena
Infectious Disease Of Indiana, Psc, Indianapolis
Local Institution, Bilbao
Local Institution, Chiang Mai
Local Institution, Kuala Lumpur
Local Institution, Recife
Local Institution, Kuala Lumpur
Local Institution, Tourcoing
Univ Of Kansas Sch Of Med, Wichita
University Of Nebraska Medical Center, Omaha
Local Institution, Lyon
Local Institution, Paris
Local Institution, Paris
Tarrant County Inf Dis Assoc, Fort Worth
The Schrader Clinic, Houston
Local Institution, Curitiba
Local Institution, Curitiba
Phoenix Body Positive, Inc, Phoenix
Rand Schrader Clinic, Los Angeles
St Francis Memorial Hospital, San Francisco
Local Institution, Le Kremlin-Bicêtre
Local Institution, Moscow
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Singapore
Local Institution, Rio de Janeiro
Cri Of New England, Boston
Local Institution, Córdoba
Local Institution, Sao Paulo - Sp
Local Institution, São Paulo
Local Institution, Hamilton
Local Institution, Montreal
Local Institution, Santiago
Local Institution, Bogota
Local Institution, Santo Domingo
Local Institution, Guatemala City
Local Institution, Guatemala City
Local Institution, Guatemala City
Local Institution, Roma
Local Institution, Mexico City
Local Institution, Lima
Local Institution, Lisbon
Local Institution, Porto
Clinical Research Puerto Rico, Inc., San Juan
V.A. Medical Center, San Juan
Local Institution, Badalona
Local Institution, Barcelona
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY